查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1941220

生殖遺傳學市場報告：按產品類型、手術類型、技術、應用和地區分類（2026-2034 年）

Reproductive Genetics Market Report by Product Type, Procedure Type, Technology, Application, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

2025年全球生殖遺傳學市場規模為91億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到622億美元，2026年至2034年的複合年成長率（CAGR）為23.87%。大眾對遺傳疾病的認知和了解不斷提高、醫療保健服務的普及以及由於出生率上升而導致的輔助生殖技術（ART）使用增加，是推動生殖遺傳學市場佔有率成長的主要因素。

生殖遺傳學市場趨勢：

全球市場的主要驅動力是大眾對遺傳疾病日益成長的認知和理解。此外，隨著醫療保健服務的普及，越來越多的父母計劃進行基因檢測，以了解其未來子女的遺傳疾病風險。出生率的上升推動了輔助生殖技術（ART）的使用，例如體外受精（IVF）和代孕，這對市場前景十分有利。相應地，先進基因檢測技術的持續發展，例如次世代定序（NGS）和高解析度微陣列，也推動了市場成長。此外，女性生育年齡的成長也增加了染色體異常的風險，這也推動了市場發展。同時，多個國家的政府加大了對基因研究和檢測的支持力度，也促進了市場成長。此外，基因測序檢測價格的不斷下降和普及也推動了市場發展。成長要素包括收入水準的提高（尤其是在開發中國家）、提供消費者基因檢測的機構的增加、個人化醫療領域的持續創新以及廣泛的研發活動。

本報告解答的關鍵問題

  • 生殖遺傳學市場規模有多大？
  • 生殖遺傳學市場的未來前景如何？
  • 推動生殖遺傳學市場發展的關鍵因素是什麼？

目錄

第1章：序言

第2章：調查範圍與調查方法

  • 調查目標
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 調查方法

第3章執行摘要

第4章 引言

第5章：全球生殖遺傳市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 按產品類型分類的市場區隔

  • 成套工具
  • 檢查室自建檢測方法（LDT）
  • 試劑和耗材

第7章 按測試類型分類的市場區隔

  • 攜帶者篩檢
  • 產前篩檢
  • 胚胎著床前遺傳學檢測
  • 不孕症基因檢測

第8章 按技術分類的市場細分

  • 次世代定序
  • 聚合酵素鏈鎖反應
  • 原位雜合反應（ISH/FISH）
  • 微陣列

第9章 按應用分類的市場細分

  • 非整倍體
  • 染色體結構異常
  • 單基因疾病
  • 其他

第10章 按地區分類的市場細分

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 促進因素、限制因素與機遇

第12章 價值鏈分析

第13章 波特五力分析

第14章：定價分析

第15章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Bangkok Genomics Innovation Public Company Limited
    • Centogene NV
    • Fulgent Genetics Inc.
    • Igenomix（Vitrolife Group）
    • Invitae Corporation
    • Laboratory Corporation of America Holdings
    • PerkinElmer Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A10134

The global reproductive genetics market size reached USD 9.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 62.2 Billion by 2034, exhibiting a growth rate (CAGR) of 23.87% during 2026-2034. The growing awareness and understanding of genetic disorders among the masses, the rising adoption of preventive healthcare, and the increasing fertility rates leading to a higher uptake of assisted reproductive technologies (ART) represent some of the key factors driving the reproductive genetics market share.

Reproductive Genetics Market Analysis:

  • Major Market Drivers: The market for reproductive genetics is driven by increasing awareness of inherited disorders, increasing use of sophisticated genetic testing, and heightened demand for customized fertility therapies. Advanced gene sequencing and diagnostic technologies, along with changing reproductive healthcare infrastructure, are pushing adoption and enhancing access to early diagnosis and intervention solutions.
  • Key Market Trends: Some of the emerging trends are non-invasive prenatal testing, preimplantation genetic testing, and implementation of artificial intelligence in diagnostics. Personalized reproductive healthcare, growth in genetic counseling services, and emphasis on predictive analytics are transforming the market. Growing partnerships among research centers and clinics further drive innovation and patient-centric reproductive solutions.
  • Competitive Landscape: The market is marked by competition based on innovation, with companies banking on technology improvement, quality of services, and strategic partnerships. Firms invest their efforts in increasing diagnostic services, precision, and patient experience. Research institutions and health providers are the usual partners in efforts to increase market presence and reach new patient bases.
  • Challenges and Opportunities: Challenges are presented in the form of ethical issues, regulatory hurdles, and the expense of sophisticated genetic testing. Low awareness in some areas also holds back adoption. Oppositely, opportunities present themselves in creating cost-effective testing options, increasing genetic counseling, and applying AI and machine learning to enhance accuracy, accessibility, and personalized reproductive healthcare outcomes.

Reproductive genetics refers to the branch of genetics that focuses on the study of genetic information and its impact on reproductive health and outcomes. It involves the analysis and understanding of genetic factors related to fertility, pregnancy, and the transmission of genetic disorders from parents to their offspring. Reproductive genetics encompasses various techniques and technologies aimed at identifying and managing genetic conditions during the reproductive process. Screening individuals or couples for specific genetic mutations or carrier status to assess the risk of passing on genetic disorders to their children. In assisted reproductive technologies such as in vitro fertilization (IVF), PGD involves the analysis of embryos for genetic abnormalities before their implantation in the uterus, helping to select embryos without specific genetic disorders. Reproductive genetics helps assess the risk of transmitting genetic disorders to offspring by identifying carrier status or the presence of specific genetic mutations in individuals or couples.

Reproductive Genetics Market Trends:

The global market is primarily driven by the growing awareness and understanding of genetic disorders among the masses. Also, the rising adoption of preventive healthcare leading to a higher number of prospective parents undergoing genetic testing to understand the risks of genetic disorders in their future children is fueling the market. With the increasing fertility rates, there is a higher uptake of assisted reproductive technologies (ART) such as In-Vitro Fertilization (IVF) and surrogacy, which is creating a positive market outlook. In line with this, continual technological developments in advanced genetic testing techniques such as Next-Generation Sequencing (NGS) and high-resolution microarrays are stimulating the market. Moreover, the increasing maternal age resulting in a higher susceptibility of chromosomal abnormalities in women is providing an impetus to the market. In addition to this, governments of several countries are increasingly supporting genetic research and testing, thereby catalyzing the growth of the market. The market is further driven by the rising affordability of genomic sequencing procedures, resulting in higher accessibility among the masses. Some of the other factors contributing to the market include inflating income levels, particularly in developing countries, the proliferation of organizations offering direct-to-consumer genetic tests, continual innovations in personalized medicine, and extensive research and development (R&D) activities.

Key Market Segmentation:

Product Type Insights:

  • Kits
  • Laboratory Developed Tests (LDT)
  • Reagents and Consumables

Procedure Type Insights:

  • Carrier Screening
  • Pre-Natal Screening
  • Pre-Implantation Genetic Testing
  • Infertility Genetic Testing

Technology Insights:

  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • In Situ Hybridization (ISH/FISH)
  • Microarray

Application Insights:

  • Aneuploidy
  • Structural Chromosomal Abnormality
  • Single Gene Disorder
  • Others

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for reproductive genetics. Some of the factors driving the North America reproductive genetics market included its continual technological advancements in the field of genetics, the rising adoption of preventive healthcare high healthcare expenditure, etc.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global reproductive genetics market. Detailed profiles of all major companies have been provided. Some of the companies covered include Bangkok Genomics Innovation Public Company Limited, Centogene N.V., Fulgent Genetics Inc., Igenomix (Vitrolife Group), Invitae Corporation, Laboratory Corporation of America Holdings, PerkinElmer Inc., Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1.How big is the reproductive genetics market?
  • 2.What is the future outlook of reproductive genetics market?
  • 3.What are the key factors driving the reproductive genetics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Reproductive Genetics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Laboratory Developed Tests (LDT)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Reagents and Consumables
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Procedure Type

  • 7.1 Carrier Screening
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pre-Natal Screening
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Pre-Implantation Genetic Testing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Infertility Genetic Testing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Next-Generation Sequencing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Polymerase Chain Reaction
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 In Situ Hybridization (ISH/FISH)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Microarray
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Aneuploidy
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Structural Chromosomal Abnormality
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Single Gene Disorder
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bangkok Genomics Innovation Public Company Limited
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Centogene N.V.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Fulgent Genetics Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Igenomix (Vitrolife Group)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Invitae Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Laboratory Corporation of America Holdings
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 PerkinElmer Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Thermo Fisher Scientific Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio

List of Figures

  • Figure 1: Global: Reproductive Genetics Market: Major Drivers and Challenges
  • Figure 2: Global: Reproductive Genetics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Reproductive Genetics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Reproductive Genetics Market: Breakup by Product Type (in %), 2025
  • Figure 5: Global: Reproductive Genetics Market: Breakup by Procedure Type (in %), 2025
  • Figure 6: Global: Reproductive Genetics Market: Breakup by Technology (in %), 2025
  • Figure 7: Global: Reproductive Genetics Market: Breakup by Application (in %), 2025
  • Figure 8: Global: Reproductive Genetics Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Reproductive Genetics (Kits) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Reproductive Genetics (Kits) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Reproductive Genetics (Laboratory Developed Tests (LDT)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Reproductive Genetics (Laboratory Developed Tests (LDT)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Reproductive Genetics (Reagents and Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Reproductive Genetics (Reagents and Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Reproductive Genetics (Carrier Screening) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Reproductive Genetics (Carrier Screening) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Reproductive Genetics (Pre-Natal Screening) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Reproductive Genetics (Pre-Natal Screening) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Reproductive Genetics (Pre-Implantation Genetic Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Reproductive Genetics (Pre-Implantation Genetic Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Reproductive Genetics (Infertility Genetic Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Reproductive Genetics (Infertility Genetic Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Reproductive Genetics (Next-Generation Sequencing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Reproductive Genetics (Next-Generation Sequencing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Reproductive Genetics (Polymerase Chain Reaction) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Reproductive Genetics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Reproductive Genetics (In Situ Hybridization (ISH/FISH)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Reproductive Genetics (In Situ Hybridization (ISH/FISH)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Reproductive Genetics (Microarray) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Reproductive Genetics (Microarray) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Reproductive Genetics (Aneuploidy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Reproductive Genetics (Aneuploidy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Reproductive Genetics (Structural Chromosomal Abnormality) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Reproductive Genetics (Structural Chromosomal Abnormality) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Reproductive Genetics (Single Gene Disorder) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Reproductive Genetics (Single Gene Disorder) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Reproductive Genetics (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Reproductive Genetics (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: North America: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: North America: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: United States: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: United States: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Canada: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Canada: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Asia-Pacific: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Asia-Pacific: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: China: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: China: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Japan: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Japan: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: India: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: India: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: South Korea: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: South Korea: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Australia: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Australia: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Indonesia: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Indonesia: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Others: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Others: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Europe: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Europe: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Germany: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Germany: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: France: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: France: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: United Kingdom: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: United Kingdom: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Italy: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Italy: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Spain: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Spain: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Russia: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Russia: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Others: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Others: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Latin America: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Latin America: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Brazil: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Brazil: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Mexico: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Mexico: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Others: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Others: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Middle East and Africa: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Middle East and Africa: Reproductive Genetics Market: Breakup by Country (in %), 2025
  • Figure 87: Middle East and Africa: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Global: Reproductive Genetics Industry: Drivers, Restraints, and Opportunities
  • Figure 89: Global: Reproductive Genetics Industry: Value Chain Analysis
  • Figure 90: Global: Reproductive Genetics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Reproductive Genetics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Reproductive Genetics Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Reproductive Genetics Market Forecast: Breakup by Procedure Type (in Million USD), 2026-2034
  • Table 4: Global: Reproductive Genetics Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 5: Global: Reproductive Genetics Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 6: Global: Reproductive Genetics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Reproductive Genetics Market: Competitive Structure
  • Table 8: Global: Reproductive Genetics Market: Key Players